Optimizing pharmacological management of the febrile child.

INTRODUCTION

Pediatric fever often causes significant parental anxiety, or 'fever phobia,' leading to the inappropriate use of antipyretics. This narrative review synthesizes current evidence to support clinical decision-making, framing fever as a regulated physiological host defense mechanism, not a disease. The primary therapeutic goal is improving the child's overall comfort, rather than simply normalizing body temperature.

AREAS COVERED: This review dispels common misconceptions, clarifying that fever height and response to antipyretics are poor predictors of illness severity. We cover evidence-based approaches to temperature measurement and the pharmacological management of symptoms, focusing on paracetamol and ibuprofen as first-line agents. Non-pharmacological strategies, such as hydration and comfort care, are described. Ultimately, we underscore the importance of clinical judgment over isolated temperature readings to guide appropriate management.

EXPERT OPINION: The management of pediatric fever is shifting from a temperature-centric paradigm to a child-centric approach focused on comfort and reducing medication misuse. Future progress hinges on harmonizing inconsistent clinical guidelines and developing advanced point-of-care diagnostics to better stratify the risk of serious bacterial infections. Overcoming 'fever phobia' remains a key challenge, requiring education and scalable digital tools. Key research priorities include validating novel biomarkers, clarifying the long-term effects of antipyretics, and implementing effective educational programs.